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Introduction
Anterior uveitis is a group of inflammatory disorders characterized by inflammation of 
the iris and ciliary body. In most cases it is difficult to control and associated with serious 
complications which can be related to the disease itself or its medications. There are many 
agents that can be used to treat anterior uveitis which include corticosteroids, nonsteroidal anti-
inflammatory agents, and immunosuppressive agents.[1] 5-Fluorouracil (5-FU) is known as a 
useful adjunct to filtering surgery in eyes at high risk of operative failure [2]. Foster & Vitale [1]
noticed that using 5-FU injections postoperatively in a patient having combined trabeculectomy 
and extra capsular cataract extraction improved the survival of trabeculectomy and markedly 
reduced the severity and duration of the post - operative inflammation. Similar observation has 
been reported earlier by Walsh et al [3]. Ophir and Ticho reported complete remission of anterior 
uveitis in patients with uveitic glaucoma who had filtering surgery and 5-FU injections post-
operatively [4], [5]. In this case series we report our experience of using 5-FU in the treatment of 
different types of anterior uveitis.
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Abstract: A case series of six patients with uncontrolled anterior uveitis of different etiology were treated with 
subconjunctival injections of 5-Fluorouracil (5-FU 5.0 mg/0.1 ml with a total dose of 15-20 mg over 2-3 weeks.
All patients showed complete remission of anterior uveitis and control of uveitic glaucoma for > 9 months. 5-
Fluorouracil might be an effective alternative to corticosteroids in controlling anterior uveitis. Patients at high 
risk of corticosteroids complications and those with uveitic glaucoma may benefit from this drug.
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Case 1
A 20- year-old female was referred to our glaucoma clinic with the diagnosis of right 
idiopathic anterior uveitis and uncontrolled intraocular pressure (IOP) on maximum tolerated 
medical treatment. The patient was diagnosed to have right idiopathic anterior uveitis five years 
ago and put on topical steroid. Two years ago, she developed uveitic glaucoma which was 
responding to topical anti-glaucoma medications. For the last 6-months her IOP became resistant 
to topical and systemic anti - glaucoma medications and she was advised to have 
trabeculectomy. On examination, her best corrected visual acuity was 20/200 OD and 20/20 OS. 
Right pupil showed relative afferent pupillary defect (RAPD). Slit lamp (SL) examination of the 
right eye showed mild conjunctival congestion, mild corneal edema, deep anterior chamber 
(AC) with 2+ cells and flare and normal iris and lens. The IOP was 36 mmHg OD and 10 mmHg 
OS. Gonioscopy of both eyes revealed open angle grade IV 360Û (Shaffer¶s classification). 
Fundus examination of the right eye showed cup/disc ratio of 0.9 with normal vitreous and 
retina. The patient was on the following drops, Pred - forte (Prednisolone Acetate) qid, 
Alphagan (Brimonidine) tid, Betagan (Levobunolol) bid, Trusopt (Dorzolamide HCl) tid and 
Diamox (Acetazolamide) 250 mg tablet qid. She was not keen to have filtering operation. The 
possibility of steroid responder behind uncontrolled IOP was discussed with the patient and she 
was offered to receive 5-FU subconjunctival injections instead of steroid. Pred - forte was 
discontinued and she was given 5 mg/0.1ml of 5-FU subconjunctival injection in the inferior 
fornix, and she was kept on all anti- glaucoma medications. 2 days later she was seen, and the 
AC reaction decreased to 1+ cell and IOP dropped to 30 mmHg. 
The patient was given a second injection of 5-FU. One week later her vision improved to 
20/60, with white conjunctiva, clear cornea, occasional cells in AC, and IOP 20 mmHg. She was 
given a third injection of 5-FU. 3 weeks later her vision improved to 20/40, with quiet AC, and 
IOP dropped to 16 mmHg.The patient continued to have quiet AC and normal IOP in the low 
teens over the following two months and all anti- glaucoma medications could be stopped except 
Betagan. No recurrence of uveitis or increase of IOP was noted in the last three years. 
Case 2
A 42 year old female presented to the glaucoma clinic on the 24th of November 2001 
complaining of pain and redness in the right eye for three weeks. She was seen in the
government eye hospital and diagnosed to have right anterior uveitis with secondary pupillary 
block glaucoma. She had YAG laser peripheral iridoctomy (PI) and put on Cosopt 
(Dorzolamide/Timolol maleate) eye drops tid, Alphagan eye drops tid, Vexol (Rimexolone) eye 
drops Qid and Diamox 250 mgt tablets qid. On examination her best corrected vision, OD 0.7 
and OS 1.0. SL examination of the right eye revealed congestion of conjunctiva, clear cornea, 
shallow AC grade (I) (Shaffer’s classification) with 1+ cell and flare, 360Û posterior synechiae 
with iris bombe and occluded PI at 12 o’clock. IOP was 50 mmHg OD and 10 mmHg OS. 
Gonioscopy of of the right eye revealed closed angle grade (0) 360Û and open angle grade (IV) 
in OS.
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All investigations excluded the possibility of uveitis. She was put on oral prednisolone 20 
mg/day with maximum tolerated anti glaucoma medications and underwent right trabeculectomy 
with Mitomycin – C (MM-C) 0.2mg/ml for 4 minutes. Post-operatively, the patient continued to 
have significant inflammation with creeping up of IOP in spite of systemic and topical steroids. 
The patient was given four injections of 5-FU 5mg/0.1ml subconjunctival in the inferior fornix 
over two weeks and had Argon laser suturlysis. She continued to have quiet eye and normal IOP 
without medications for two years.
Case 3
A 78 year old male patient, who had on the 2nd of February 2002 uncomplicated left 
extra capsular cataract extraction and posterior chamber intra-ocular lens (IOL) implantation. 
Postoperative course was routine and uneventful. On 26th of March 2002, he came to the clinic 
complaining of pain and floaters for two days after he discontinued Maxitrol (Dexamethasone, 
Neomycin, Polymyxin B sulphate) drop and ointment. Examination of the left eye showed best 
corrected vision of 20/60, SL examination showed congestion of conjunctiva, clear cornea, with 
deep AC full of cells and presence of hypopyon. IOP was15 mm Hg. Gonioscopy revealed grade 
IV open angle. On dilating the pupil, fluffy white material (plaque) could be seen behind the 
IOL on the nasal side and the retina could be examined easily with the indirect ophthalmoscope 
in spite of 1+ cell in the anterior vitreous. The patient was diagnosed to have severe uveitis 
secondary to cortical material or questionable sterile endophthalmitis. He was admitted to 
hospital and received endophthalmitis treatment regimen in form of fortified drops of 
Gentamycin 13mg/ml, and Cefazolin 50mg/ml on alternating hours, and IV Gentamycin 80mg 
q8h, and Cefazolin 250 mg q6h for five days, and Pred- forte drop qid. He responded well, the 
hypopyon disappeared after three days and his vision improved. The patient was discharged 
home on the 6th day on oral prednisolone 5mg Bid, fortified Gentamycin and Cefazolin drops 
qid, and Pred forte qid. 
On tapering the medications the inflammation flared up.The patient was admitted to 
hospital and treated as a case of chronic endophthalmitis secondary to questionable Proprioni-
bacterium acne and had vitreous tap for culture and sensitivity. Intravitreal Vancomycin 
1mg/0.1ml and Amikacin 0.4mg/0.1ml were given. He was put on Pred forte and Oflox 
(Ofloxacin) drops Qid. Culture turned to be negative. In spite of the above measures the patient 
deteriorated. AC tapped and sample was obtained from the white material behind the IOL and 
Vancomycin and Gentamycin were injected at that area. The patient was put on endophthalmitis 
treatment regimen. Culture showed coagulase-negative staphylococcus aureus, sensitive to 
Gentamycin. The patient improved and discharged home on Pred forte gtt Qid and fortified 
Gentamycin Q3h and oral Prednisolone 20 mg/ day. The treatment was tapered over three weeks 
and when the Pred forte stopped and the oral Prednisolone dose became 5mg/day the 
inflammation flared up. Informed consent about using 5-FU injection to control inflammation 
was taken from the patient before subjecting him to vitrectomy, removal of IOL and intravitreal 
antibiotic. The patient received three subconjunctival injections of 5-FU 5mg/0.1 ml over three 
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weeks. The eye became quiet and the white plaque disappeared and his vision improved to 20/25 
without medications since then.
Case 4
A 20 year old male was seen at our uveitis clinic complaining of pain and decrease of 
vision in the right eye for 3 days. He is a known case of recurrent idiopathic iridocyclitis and 
was fully investigated 2 years ago at our institute with negative results.
On ocular examination, his best corrected vision was 20/60 OD and 20/20 OS. Pupils 
were equal and reactive with no RAPD. SL examination of the right eye revealed conjunctival 
congestion with ciliary flush and deep AC with 3+ cells and flare and posterior synechia at 2 
o’clock with normal lens.Fundus examination showed 1+ cells at the anterior vitreous and I.O.P 
of 16 mmHg in both eyes with normal retina of the right eye.Patient was diagnosed to have right 
recurrent idiopathic iridocyclitis and was started on Pred- forte drops every hour and 
Cyclopentolate 1% drops tid. One week later vision improved to 20/40 with 2+ cells and flare. 2 
weeks later vision improved to 20/30 with 1+ cell and flare and IOP was 30 mmHg. The patient 
was started on Cosopt (Dorzolamide/Timolol maleate) drops bid and Pred forte reduced to qid. 
One week later his IOP dropped to 18 mmHg. Pred forte was reduced slowly over 6weeks down 
to once a day and Cyclopentolate stopped. The patient developed recurrence of his uveitis with 
4+ cells and flares. Pred forte increased to q 1 h. A week later his inflammation markedly 
reduced but his IOP increased to 28mmHg. Since the patient was a steroid responder; Pred -
forte was replaced by Acular (Ketorolac tromethamine) drops qid. He also was given three 
injections of 5-FU 5 mg/0.1 ml subconjunctival over three consecutive weeks. His vision 
improved to 20/20 with complete resolution of iritis and his IOP reduced to 16 mmHg. Acular 
and Cosopt were stopped after two months with no recurrence of inflammation or glaucoma for 
more than 12 months of follow up.
Case 5
A 30 year old male patient with a known history of Ankylosing Spondylitis for 5 years; 
presented to our uveitis clinic with a history of pain and redness in his right eye for 3 days. He 
gave a history of recurrent iritis in this eye for the last 18 months. He had 4 attacks, each lasted
for 6 to 8 weeks and responded to topical corticosteroids.
On ocular examination, his best corrected vision was 20/50 OD and 20/20 OS. Pupils 
were reactive OU with no RAPD. SL examination of the right eye revealed ciliary flush with 
mild diffuse conjunctival congestion, and the anterior chamber was deep with 4+ cells and flare 
and fine KPs over the lower one third of the endothelium. Iris and lens were normal. Slit lamp 
evaluation of the left eye was within normal. Fundus exam was normal in both eyes, and the 
intra-ocular pressure was 16 mmgH OD and 17 mmHg OS.
The patient was diagnosed to have iritis of the right eye and put on Pred - forte drops 
every hour and Cyclopentolate 1% T/D. Since the attacks were so frequent; he was offered to be 
treated by 5-FU. Three sub conjunctival injections of 5-FU 5mg/0.1ml each were given over
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3 weeks. At the end of the 3rd week his visual acuity improved to 20/20, the anterior chamber 
was clear and IOP was 16 mmHg. Pred -forte was tapered over 6 weeks and he had no 
recurrence for more than two years.
Case 6
A 36 year-old lady presented to our uveitis clinic with a history of severe pain in her left 
eye for two weeks. She had left recurrent attacks of iritis for the last 6 years and was fully 
investigated with no evidence of underlying etiology. She was on Timolol 0.5% eye drops bid to 
her left eye for the last 3 years.On ocular examination, her best corrected visual acuity was 
20/25 OD and 20/100 OS. Pupils were reactive in both eyes with RAPD of OS. SL examination 
of the right eye was within normal. Left eye showed diffuse conjunctival congestion with mild 
corneal edema. Anterior chamber was deep with 2+ cells and flares, iris evaluation showed 
posterior synechiae extending from 12 to 8 o’clock. Lens examination revealed posterior sub-
capsular cataract.The vitreous and retina were normal in both eyes. Cup/disc ratio was 0.1 OD 
and 0.8 OS, with an IOP of 15 mmHg OD and 26 mmHg OS.The patient was diagnosed to have 
left idiopathic iritis with uncontrolled glaucoma. She was put on Vexol (Rimexolone) 1% drops 
every hours, Mydriacyl (Tropicamide) 1% tid, and Alphagan ( Brimonidine )0.2% bid.One week 
later her vision was the same, the anterior chamber evaluation showed 1+ cells and flare and IOP 
was 23 mmHg. Vexol was reduced to Qid and Acular 0.5% drops Qid was added. Ten days later 
she was seen, and the anterior chamber showed 1+ cells and flare, with an IOP of 23 mmHg.The 
Patient was given 3 subconjunctival injections of 5-FU 5mg/0.1ml each over a period of three 
weeks. At the end of the 3rd week, the patient maintained the same visual acuity,  the AC showed 
occasional cells, no flare and IOP was 21 mmHg. Vexol was tapered over 4 weeks and she was 
kept on Mydriacyl 1% tid, Acular 0.5% QID, Timolol 0.5% bid, and Alphagan 0.2% bid. At 9 
months follow up, the anterior chamber was quiet in her left eye and IOP was 18mmHg while 
she was on above medications.
Results
The demographics and clinical characteristics of the studied cases are shown in Table 1.
Table 1:  The demographics and clinical characteristics of the studied cases
Case No
Age 
years)( Sex
Affected 
eye
Type of 
Uveitis
Duration 
of Uveitis 
(Years)
Glaucoma
Visual 
Acuity
IOP
(mmHg)
Anterior 
Chamber 
Reaction
1 20 Female Right Idiopathic 5 Present 20/200 36 2+cells
2 42 Female Right Idiopathic` 0.5 Present 20/40 50 1+cells
3 78 Male Left Secondary 
to Cortex
0.2 None 20/60 15 4+cells and 
Hypopyon
4 20 Male Right Idiopathic 2 Present 20/60 30 3+cells
5 30 Male Right Idiopathic 1.5 None 20/50 16 4+cells
6 30 Female Left Idiopathic 6 Present 20/100 26 2+cells
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The Effect of Treatment with 5-FU on the Anterior Uveitis cases is presented in Table 2.
Table 2:  The effect of treatment with 5-FU on the anterior uveitis cases
Case No
Frequency
(No of 
injections)
Visual Acuity IOP mmHG
Anterior 
Chamber 
Reaction
Follow up Period
1 3 20/40 16 None 3 years
2 4 20/20 14 None 2 years
3 3 20/25 14 None 4 years
4 3 20/20 16 None 1 years
5 3 20/20 16 None 2 years
6 3 20/100 18 None 9 months
Discussion
Five-fluorouracil (5-FU) is a potent antimetabolic agent. It is a pyrimidine base 
analogue; it has a cell-cycle specific antimetabolic activity that acts during the S phase of the 
cell cycle. It is converted to 5-F DUMP, which inhibits thymidylate synthetase, preventing DNA 
and RNA synthesis because of a lack of thymidine. This results in disturbed cell growth and 
death of cells[2]. It controls uveitis by inhibiting the reproductive ability of lymphoid cells, which 
in turn interferes with its both humoral and cell-mediated immunity [5]. It was the first 
chemotherapeutic agent to be successfully used to reduce filter failure in high-risk surgical 
cases[2]. The first report on the effect of 5-FU in the control of anterior uveitis was published in 
the literature by Ophir and Ticho [5]. They noticed remission of anterior uveitis for about 8 
months, in 3 eyes with inflammatory glaucoma, which had filtering surgery. These eyes received 
one to two subconjunctival injections per day of 5-FU for a duration of 7 to 14 days to prevent 
bleb scarring.
In our series we described six cases; 5 cases with idiopathic anterior uveitis, and one case 
(No.3) with chronic secondary anterior uveitis (endophthalmitis). All cases responded well to 5-
FU subconjunctival injections, and were free of a relapse for > 9 months. We used relatively low 
total dose (15 -20 mg) of 5-FU comparable to the high dose (35-130 mg) used by Ophir and 
Ticho.[5]  This could be the reason that none ofour patients had any complication related to 5-FU 
use. In case (No.2), 5-FU injections were successfully used as an adjunct to MM-C to control 
inflammation and prevent bleb scarring and failure. In case (No.3).the patient had chronic 
secondary anterior uveitis (endophthalmitis) after uneventful cataract surgery. He had white 
posterior capsular plaque from which coagulase-negative Staphylococcus aureus was isolated. 
Previous studies showed that the plaque consists of a mixture of lens material and colonies of 
microorganisms [6-7], including coagulase-negative Staphylococcus aureus, which could produce 
intraocular abscess masquerading chronic uveitis [8]. Most cases of chronic infectious 
postoperative to endophthalmitis will go on to require some type of surgical treatment due to 
recurrent or persistent inflammation. [6-7]. This was avoided in our patient by using 5-FU 
injections.
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Glaucoma is most commonly associated with chronic anterior uveitis. It is due to 
obstruction of the trabecular meshwork by inflammatory cells and debris [9-10], and or Steroid 
which is used in the treatment of uveitis [11, 12]. In conclusion, 5-FU as an anti-inflammatory 
agent could replace steroid in controlling uveitis and glaucoma secondary to uveitis and or 
steroid therapy. Long term follow up is needed to confirm its long term efficacy. 
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